{"id":"W3202510981","doi":"10.1136/annrheumdis-2021-220920","title":"B-cell depletion with obinutuzumab for the treatment of proliferative lupus nephritis: a randomised, double-blind, placebo-controlled trial","year":2022,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Systemic Lupus Erythematosus Research","field":"Medicine","cited_by":438,"is_retracted":false,"has_abstract":true,"ca_institutions":"Roche (Canada)","funders":"F. Hoffmann-La Roche","keywords":"Obinutuzumab; Medicine; Placebo; Internal medicine; Clinical endpoint; Rituximab; Lupus nephritis; CD20; Gastroenterology; Surgery; Clinical trial; Lymphoma; Pathology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007054172,0.0002394619,0.001090794,0.0001191165,0.0003281027,0.00002563508,0.0003239088,0.00003553292,0.0001417071],"category_scores_gemma":[0.00034605,0.000108861,0.0007450667,0.0002739833,0.0001873938,0.00005450186,0.00006301051,0.00008601387,0.000002152207],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001812726,"about_ca_system_score_gemma":0.001063967,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0001141004,"about_ca_topic_score_gemma":0.00001239882,"domain_scores_codex":[0.9972131,0.0004710296,0.0007710421,0.0002515517,0.0009784801,0.0003147667],"domain_scores_gemma":[0.9959529,0.002250568,0.0006353693,0.0007115963,0.0003316623,0.0001178938],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9873604,0.002041096,0.0004168964,0.0007332847,0.001700337,0.000003431089,0.002494885,0.0005937101,0.00002777491,0.0001265612,0.003542896,0.0009586865],"study_design_scores_gemma":[0.9848976,0.005858291,0.00001998992,0.0004921508,0.001207301,0.0002105941,0.003371276,0.002257864,0.0009833815,0.000207853,0.0003792861,0.0001144734],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9581571,0.007602816,0.00009432258,0.00152169,0.0003139775,0.03190565,0.0001210112,0.00002535929,0.0002581255],"genre_scores_gemma":[0.9750201,0.0007429899,0.00003760798,0.00007185366,0.00008308183,0.02144709,0.00002928777,0.00003796052,0.002530009],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.01686307,"threshold_uncertainty_score":0.4439221,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.05956355332456594,"score_gpt":0.3332283862371711,"score_spread":0.2736648329126052,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}